INS and type 1 diabetes mellitus: With regards to both glycemic outcomes and patient satisfaction, the results of our adult cohort are in line with those of the recently published pediatric study [12], therefore confirming that diabetes devices are beneficial in the whole spectrum of patients with type 1 diabetes, and HCL/AHCL systems represent nowadays the gold standard of insulin replacement treatment [25].